How would you approach potential SBRT to liver metastases in a patient on a VEGF inhibitor?  

Would you alter your SBRT dose? How long would you hold the VEGF inhibitor before and after? Does the primary matter (e.g. NSCLC vs. colorectal)?

Answer from: Radiation Oncologist at Academic Institution
Radiation Oncologist at UCLA | VA Greater Los Angeles Healthcare System
This is a great scenario in which to consider a tr...
Sign in or Register to read more